These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 500133)

  • 21. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical studies of complement activation.
    Garrigue MA; Muh JP; Bardos P
    Clin Chim Acta; 1983 Aug; 132(2):117-25. PubMed ID: 6616867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors.
    Korbelik M; Sun J; Cecic I; Serrano K
    Photochem Photobiol Sci; 2004 Aug; 3(8):812-6. PubMed ID: 15295639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidate inhibitors of porcine complement.
    Thorgersen EB; Ghebremariam YT; Thurman JM; Fung M; Nielsen EW; Holers VM; Kotwal GJ; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1827-34. PubMed ID: 17109963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. I. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues.
    Riches DW; Stanworth DR
    Immunology; 1981 Sep; 44(1):29-39. PubMed ID: 7275186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the mechanism of haemopoietic stem cell (CFUs) mobilization. A role of the complement system.
    Wilschut IJ; Erkens-Versluis ME; Ploemacher RE; Benner R; Vos O
    Cell Tissue Kinet; 1979 May; 12(3):299-311. PubMed ID: 476778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of complement anaphylatoxin assays.
    Hammerschmidt DE
    Complement; 1986; 3(3):166-76. PubMed ID: 3542365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of immunological adjuvants.
    Trier NH; Güven E; Skogstrand K; Ciplys E; Slibinskas R; Houen G
    APMIS; 2019 Sep; 127(9):635-641. PubMed ID: 31237033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of rat intestinal glycoprotein on complement lytic activity of 32P-labelled Escherichia coli.
    Winsnes R; Midtvedt T; Mellbye OJ
    Scand J Immunol; 1978; 7(6):467-72. PubMed ID: 356178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties.
    Cooper PD; Steele EJ
    Vaccine; 1991 May; 9(5):351-7. PubMed ID: 1872020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-complementary action of polymorphic "solubility forms" of particulate inulin.
    Cooper PD; Carter M
    Mol Immunol; 1986 Aug; 23(8):895-901. PubMed ID: 3796631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of complement activation in vitro by sodium meglumine ioxitalamate.
    Freyria AM; Billet F; Eloy R; Traeger J
    Int Arch Allergy Appl Immunol; 1983; 71(4):357-62. PubMed ID: 6862664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of zymosan-induced complement activation by CH50 test.
    Ceroni M; Camana C; Giardini G; Savoldi F; Fumagalli M
    Farmaco Prat; 1986 Apr; 41(4):147-54. PubMed ID: 3720925
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?
    Szebeni J
    Drug Discov Today; 2018 Mar; 23(3):487-492. PubMed ID: 29326077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of blood complement in guinea pigs receiving an intravenous injection of Sephadex beads.
    Blain JF; Maghni K; Sirois P
    Inflamm Res; 1995 Aug; 44 Suppl 2():S158-9. PubMed ID: 8548376
    [No Abstract]   [Full Text] [Related]  

  • 36. Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?
    Peakman M; Senaldi G; Vergani D
    J Clin Pathol; 1989 Oct; 42(10):1018-25. PubMed ID: 2685048
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticomplementary activity of cinnarizine, and the relationship between complement and arteriosclerosis].
    Yamauchi Y; Matsumoto J; Horimatsu T; Isobe T
    Nihon Rinsho; 1981 Jan; 39(1):195-9. PubMed ID: 7289051
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the occurrence of zirconium in some organs in the guinea pig and man and its modification, especially by mercury].
    STEPAN J; FRIDRICH E
    Med Exp Int J Exp Med; 1961; 5():15-9. PubMed ID: 13916846
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccines combining slow delivery and follicle targeting of antigens increase germinal center B cell clonal diversity and clonal expansion.
    Rodrigues KA; Zhang YJ; Aung A; Morgan DM; Maiorino L; Yousefpour P; Gibson G; Ozorowski G; Gregory JR; Amlashi P; Buckley M; Ward AB; Schief WR; Love JC; Irvine DJ
    bioRxiv; 2024 Aug; ():. PubMed ID: 39229011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research Progress of Aluminum Phosphate Adjuvants and Their Action Mechanisms.
    Zhang T; He P; Guo D; Chen K; Hu Z; Zou Y
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.